Researchers Found A Liver Drug That Could Cure Parkinson's
Sep 04, 2013 11:26
Parkinson's disease progressively robs patients of their physical abilities. So far, we haven't found a way to stop brain cells from dying. Up until now. Researchers are making progress in the UK and Norway and have found a drug that could keep brain cells functioning normally. The drug has been used to treat liver disease for years.
Led by Sheffield Institute for Translational Neuorscience's Dr. Oliver Bandmann, they discovered the drug ursodeoxycholic acide (UDA) helps heal faulty mitochondria. The drug is used to treat gallstones and some forms of cirrhosis and was found to be the most effective among 2,000 compounds tested on mitochondria skin cells from Parkinson's patients.
Researchers will be able to move to clinical trials with UDA to determine the drug's safety and optimum dosage in Parkinson's patients. We're one step closer, folks. One step closer. [The University of Sheffield via ScienceDaily]
Running your business can be overwhelming at times. You want to make sure your employees are present, that payment options are easy and seamless for clients, and you want your database marketing to be on point at all times. Is there a piece of equipment that can run your credit card processing while also helping you store your database marketing ideas? Yes, there is. The Clover pos systems by Merchant Account Solutions offer you a great way to run your company from the palm of your hand. Read more
Lots of people are focused on how we're going to escape our planet. They want to colonize another world because it's only a matter of time before earth becomes uninhabitable. Maybe they're getting too far ahead of themselves and they should be focusing their efforts on something else. Read more
Quite a lot of people started making a living off Youtube recently. As Youtube has started accommodating video-makers to a greater extent, it has become more commercial. From Vlogs to tutorials, you can find channels producing every kind of content for their fans. Read more